Global and China Biologics Contract Development and Manufacturing Organization (CDMO) Market Size, Status and Forecast 2021-2027

Global and China Biologics Contract Development and Manufacturing Organization (CDMO) Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biologics Contract Development Services
1.2.3 Biologics Contract Manufacturing Services
1.3 Market by Application
1.3.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Big Pharma
1.3.3 Small Pharma
1.3.4 Generic Pharma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Perspective (2016-2027)
2.2 Biologics Contract Development and Manufacturing Organization(CDMO) Growth Trends by Regions
2.2.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biologics Contract Development and Manufacturing Organization(CDMO) Historic Market Share by Regions (2016-2021)
2.2.3 Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Regions (2022-2027)
2.3 Biologics Contract Development and Manufacturing Organization(CDMO) Industry Dynamic
2.3.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Trends
2.3.2 Biologics Contract Development and Manufacturing Organization(CDMO) Market Drivers
2.3.3 Biologics Contract Development and Manufacturing Organization(CDMO) Market Challenges
2.3.4 Biologics Contract Development and Manufacturing Organization(CDMO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Contract Development and Manufacturing Organization(CDMO) Players by Revenue
3.1.1 Global Top Biologics Contract Development and Manufacturing Organization(CDMO) Players by Revenue (2016-2021)
3.1.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Players (2016-2021)
3.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biologics Contract Development and Manufacturing Organization(CDMO) Revenue
3.4 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Concentration Ratio
3.4.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Contract Development and Manufacturing Organization(CDMO) Revenue in 2020
3.5 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players Head office and Area Served
3.6 Key Players Biologics Contract Development and Manufacturing Organization(CDMO) Product Solution and Service
3.7 Date of Enter into Biologics Contract Development and Manufacturing Organization(CDMO) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Contract Development and Manufacturing Organization(CDMO) Breakdown Data by Type
4.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Historic Market Size by Type (2016-2021)
4.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Type (2022-2027)
5 Biologics Contract Development and Manufacturing Organization(CDMO) Breakdown Data by Application
5.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Historic Market Size by Application (2016-2021)
5.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2016-2027)
6.2 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
6.2.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021)
6.2.2 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027)
6.2.3 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2027)
6.3 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application
6.3.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021)
6.3.2 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027)
6.3.3 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2027)
6.4 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country
6.4.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021)
6.4.2 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2016-2027)
7.2 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
7.2.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021)
7.2.2 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027)
7.2.3 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2027)
7.3 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application
7.3.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021)
7.3.2 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027)
7.3.3 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2027)
7.4 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country
7.4.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021)
7.4.2 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2016-2027)
8.2 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
8.2.1 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2027)
8.3 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application
8.3.1 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2027)
8.4 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region
8.4.1 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2016-2027)
9.2 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
9.2.1 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021)
9.2.2 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027)
9.2.3 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2027)
9.3 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application
9.3.1 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021)
9.3.2 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027)
9.3.3 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2027)
9.4 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country
9.4.1 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021)
9.4.2 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2016-2027)
10.2 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
10.2.1 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2027)
10.3 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application
10.3.1 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2027)
10.4 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country
10.4.1 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.1.4 Lonza Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.1.5 Lonza Recent Development
11.2 Hansen
11.2.1 Hansen Company Details
11.2.2 Hansen Business Overview
11.2.3 Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.2.4 Hansen Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.2.5 Hansen Recent Development
11.3 Boehringer Ingelheim BioXcellence
11.3.1 Boehringer Ingelheim BioXcellence Company Details
11.3.2 Boehringer Ingelheim BioXcellence Business Overview
11.3.3 Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.3.4 Boehringer Ingelheim BioXcellence Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.3.5 Boehringer Ingelheim BioXcellence Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.4.4 Thermo Fisher Scientific Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Samsung BioLogics
11.5.1 Samsung BioLogics Company Details
11.5.2 Samsung BioLogics Business Overview
11.5.3 Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.5.4 Samsung BioLogics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.5.5 Samsung BioLogics Recent Development
11.6 AGC Biologics
11.6.1 AGC Biologics Company Details
11.6.2 AGC Biologics Business Overview
11.6.3 AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.6.4 AGC Biologics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.6.5 AGC Biologics Recent Development
11.7 Catalent
11.7.1 Catalent Company Details
11.7.2 Catalent Business Overview
11.7.3 Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.7.4 Catalent Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.7.5 Catalent Recent Development
11.8 Wuxi Biologics
11.8.1 Wuxi Biologics Company Details
11.8.2 Wuxi Biologics Business Overview
11.8.3 Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.8.4 Wuxi Biologics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.8.5 Wuxi Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biologics Contract Development Services
Table 3. Key Players of Biologics Contract Manufacturing Services
Table 4. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Regions (2016-2021)
Table 8. Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Regions (2022-2027)
Table 10. Biologics Contract Development and Manufacturing Organization(CDMO) Market Trends
Table 11. Biologics Contract Development and Manufacturing Organization(CDMO) Market Drivers
Table 12. Biologics Contract Development and Manufacturing Organization(CDMO) Market Challenges
Table 13. Biologics Contract Development and Manufacturing Organization(CDMO) Market Restraints
Table 14. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Players (2016-2021)
Table 16. Global Top Biologics Contract Development and Manufacturing Organization(CDMO) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) as of 2020)
Table 17. Ranking of Global Top Biologics Contract Development and Manufacturing Organization(CDMO) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biologics Contract Development and Manufacturing Organization(CDMO) Product Solution and Service
Table 21. Date of Enter into Biologics Contract Development and Manufacturing Organization(CDMO) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Type (2016-2021)
Table 25. Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Application (2016-2021)
Table 29. Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Lonza Company Details
Table 62. Lonza Business Overview
Table 63. Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Product
Table 64. Lonza Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 65. Lonza Recent Development
Table 66. Hansen Company Details
Table 67. Hansen Business Overview
Table 68. Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Product
Table 69. Hansen Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 70. Hansen Recent Development
Table 71. Boehringer Ingelheim BioXcellence Company Details
Table 72. Boehringer Ingelheim BioXcellence Business Overview
Table 73. Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Product
Table 74. Boehringer Ingelheim BioXcellence Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 75. Boehringer Ingelheim BioXcellence Recent Development
Table 76. Thermo Fisher Scientific Company Details
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Product
Table 79. Thermo Fisher Scientific Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 80. Thermo Fisher Scientific Recent Development
Table 81. Samsung BioLogics Company Details
Table 82. Samsung BioLogics Business Overview
Table 83. Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Product
Table 84. Samsung BioLogics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 85. Samsung BioLogics Recent Development
Table 86. AGC Biologics Company Details
Table 87. AGC Biologics Business Overview
Table 88. AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product
Table 89. AGC Biologics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 90. AGC Biologics Recent Development
Table 91. Catalent Company Details
Table 92. Catalent Business Overview
Table 93. Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Product
Table 94. Catalent Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 95. Catalent Recent Development
Table 96. Wuxi Biologics Company Details
Table 97. Wuxi Biologics Business Overview
Table 98. Wuxi Biologics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 99. Wuxi Biologics Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Type: 2020 VS 2027
Figure 2. Biologics Contract Development Services Features
Figure 3. Biologics Contract Manufacturing Services Features
Figure 4. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application: 2020 VS 2027
Figure 5. Big Pharma Case Studies
Figure 6. Small Pharma Case Studies
Figure 7. Generic Pharma Case Studies
Figure 8. Other Case Studies
Figure 9. Biologics Contract Development and Manufacturing Organization(CDMO) Report Years Considered
Figure 10. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Regions: 2020 VS 2027
Figure 13. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Regions (2022-2027)
Figure 14. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Players in 2020
Figure 15. Global Top Biologics Contract Development and Manufacturing Organization(CDMO) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Biologics Contract Development and Manufacturing Organization(CDMO) Revenue in 2020
Figure 17. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Type (2016-2021)
Figure 18. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Type (2022-2027)
Figure 19. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Type (2016-2027)
Figure 21. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application (2016-2027)
Figure 22. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Country (2016-2027)
Figure 23. United States Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Type (2016-2027)
Figure 27. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application (2016-2027)
Figure 28. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Country (2016-2027)
Figure 29. Germany Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Region (2016-2027)
Figure 39. China Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Biologics Contract Development and Manu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs